Shares of health-care companies were about flat as traders rotated into more economically sensitive areas. Adamas Pharmaceuticals shares shot up after the Food and Drug Administration approved its treatment in patients with Parkinson's disease, Gocovri, in combination with another medicine.
Continue Reading Below
-Rob Curran, email@example.com
(END) Dow Jones Newswires
August 25, 2017 16:34 ET (20:34 GMT)